U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H21F2N3O4S
Molecular Weight 449.471
Optical Activity ( - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, ((3R,5R)-

SMILES

CC1=CC=C(C=C1)S(=O)(=O)OC[C@H]2CO[C@](CN3C=NC=N3)(C2)C4=C(F)C=C(F)C=C4

InChI

InChIKey=DFWVLCJRFGIRAK-IERDGZPVSA-N
InChI=1S/C21H21F2N3O4S/c1-15-2-5-18(6-3-15)31(27,28)30-11-16-9-21(29-10-16,12-26-14-24-13-25-26)19-7-4-17(22)8-20(19)23/h2-8,13-14,16H,9-12H2,1H3/t16-,21+/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
139594
Name Type Language
5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, ((3R,5R)-
Systematic Name English
1,4-Anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-D-erythro-pentitol
Systematic Name English
D-erythro-Pentitol, 1,4-anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-
Systematic Name English
((3R,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate
Systematic Name English
1,4-Anhydro-2,3,5-trideoxy-4-C-(2,4-difluorophenyl)-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-5-(1H-1,2,4-triazol-1-yl)-D-erythro-pentitol
Systematic Name English
(5R-trans)-Toluene-4-sulfonic Acid 5-(2,4-Difluorophenyl)-5-[1,2,4]triazol-1-ylmethyltetrahydrofuran-3-ylmethyl ester
Systematic Name English
Code System Code Type Description
CAS
159811-30-0
Created by admin on Sat Dec 16 19:55:41 GMT 2023 , Edited by admin on Sat Dec 16 19:55:41 GMT 2023
PRIMARY
PUBCHEM
15238247
Created by admin on Sat Dec 16 19:55:41 GMT 2023 , Edited by admin on Sat Dec 16 19:55:41 GMT 2023
PRIMARY
FDA UNII
RZ43E8WQY3
Created by admin on Sat Dec 16 19:55:41 GMT 2023 , Edited by admin on Sat Dec 16 19:55:41 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966